Becker's Healthcare December 3, 2021
Katie Adams

The COVID-19 vaccines made by Pfizer and Moderna are most effective at boosting antibody levels among fully vaccinated adults, according to a study published Dec. 2 in The Lancet.

The study, which took place in the U.K. over the summer, involved 2,878 adults ages 30 and older. Researchers analyzed the safety and efficacy of seven vaccines administered to participants after they received two initial doses of either AstraZeneca’s vaccine or Pfizer’s vaccine. The seven vaccines were produced by AstraZeneca, Pfizer, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.

Four key findings:

  1. All seven vaccines...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing

Share This Article